A 68-year-old with symptomatic peripheral artery disease after femoropopliteal stenting asks about secondary prevention. He has no major bleeding hist...

Question

A 68-year-old with symptomatic peripheral artery disease after femoropopliteal stenting asks about secondary prevention. He has no major bleeding history. Which antithrombotic strategy best reduces MACE/MALE?

Accepted Answer

Aspirin 81 mg daily plus rivaroxaban 2.5 mg twice daily

Answer

Clopidogrel monotherapy

Answer

Warfarin with target INR 2.5

Answer

Dual antiplatelet therapy with aspirin and clopidogrel indefinitely

Answer

No antithrombotic therapy

us-abim MCQ (SBA): Peripheral Artery Disease

A 68-year-old with symptomatic peripheral artery disease after femoropopliteal stenting asks about secondary prevention. He has no major bleeding history. Which antithrombotic strategy best reduces MACE/MALE?